| Lack of FOS/FOSB Gene Rearrangements in Ischemic Fasciitis Indicates Distinct Pathogenesis from Proliferative Fasciitis and Proliferative Myositis. | Lack of FOS/FOSB Gene Rearrangements in Ischemic Fasciitis Indicates Distinct Pathogenesis from Proliferative Fasciitis and Proliferative Myositis.
Zilla ML, Naous R, John I. | 06/25/2024 |
| Single cell RNA-seq identifies a FOS/JUN-related monocyte signature associated with clinical response of heart failure patients with mesenchymal stem cell therapy. | Single cell RNA-seq identifies a FOS/JUN-related monocyte signature associated with clinical response of heart failure patients with mesenchymal stem cell therapy.
Yuan H, Zhang P, Xin Y, Liu Z, Gao B., Free PMC Article | 04/12/2024 |
| Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS. | Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS.
Yang F, Cui X, Wang H, Zhang D, Luo S, Li Y, Dai Y, Yang D, Zhang X, Wang L, Zheng G, Zhang X. | 02/6/2024 |
| Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. | Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
Nanamiya T, Takane K, Yamaguchi K, Okawara Y, Arakawa M, Saku A, Ikenoue T, Fujiyuki T, Yoneda M, Kai C, Furukawa Y., Free PMC Article | 01/10/2024 |
| Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study. | Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study.
Angioni MM, Floris A, Cangemi I, Congia M, Chessa E, Naitza MR, Piga M, Cauli A., Free PMC Article | 11/20/2023 |
| Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer. | Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer.
Lu K, Wang HC, Tu YC, Chang CC, Lou PJ, Chang TC, Lin JJ. | 11/15/2023 |
| Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells. | Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells.
Malsy M, Graf B, Bruendl E, Maier-Stocker C, Bundscherer A. | 11/3/2023 |
| New kids on the block: FOS and FOSB gene. | New kids on the block: FOS and FOSB gene.
Cordier F, Creytens D. | 10/28/2023 |
| Overexpression of MiR-181c-5p Attenuates Human Umbilical Vascular Endothelial Cell Injury in Deep Vein Thrombosis by Targeting FOS. | Overexpression of MiR-181c-5p Attenuates Human Umbilical Vascular Endothelial Cell Injury in Deep Vein Thrombosis by Targeting FOS.
Yang F, Chen D, Liu Y, Zhang X, Su Y, Zhang X, Yin Z, Wu J. | 10/25/2023 |
| Protection of c-Fos from autophagic degradation by PRMT1-mediated methylation fosters gastric tumorigenesis. | Protection of c-Fos from autophagic degradation by PRMT1-mediated methylation fosters gastric tumorigenesis.
Kim E, Rahmawati L, Aziz N, Kim HG, Kim JH, Kim KH, Yoo BC, Parameswaran N, Kang JS, Hur H, Manavalan B, Lee J, Cho JY., Free PMC Article | 08/16/2023 |
| c-FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myeloma. | c-FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myeloma.
Osada N, Kikuchi J, Iha H, Yasui H, Ikeda S, Takahashi N, Furukawa Y., Free PMC Article | 08/16/2023 |
| Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis. | Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis.
Matsuoka K, Bakiri L, Bilban M, Toegel S, Haschemi A, Yuan H, Kasper M, Windhager R, Wagner EF., Free PMC Article | 08/16/2023 |
| Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis. | Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X, Bai F, Wang Y, Wang C, Chan HL, Zheng C, Fang J, Zhu WG, Pei XH., Free PMC Article | 06/30/2023 |
| C-Fos-activated circRPPH1 contributes to glioma stemness. | C-Fos-activated circRPPH1 contributes to glioma stemness.
Xu G, Qu J, Zhang M, Wang Q. | 04/26/2023 |
| Toll-Like Receptor Signaling in the Pathogenesis of Chronic Dacryocystitis: Implication of c-FOS Transcription Factor and its Downstream Effector Chemokine Genes CCL2, CCL4, CXCL3, CXCR4 with a Shift of the M1/M2 Macrophage Phenotype. | Toll-Like Receptor Signaling in the Pathogenesis of Chronic Dacryocystitis: Implication of c-FOS Transcription Factor and its Downstream Effector Chemokine Genes CCL2, CCL4, CXCL3, CXCR4 with a Shift of the M1/M2 Macrophage Phenotype.
Edris NA, Aboulhoda BE, El-Din SS, Fouad AM, Albadawi E, Rashed LA, Elessawy KB. | 03/9/2023 |
| Inflammatory lobular hemangioma (T-cell-rich angiomatoid polypoid pseudolymphoma)-Assessment of FOS/FOSB and lymphoid markers and comparison with epithelioid hemangioma. | Inflammatory lobular hemangioma (T-cell-rich angiomatoid polypoid pseudolymphoma)-Assessment of FOS/FOSB and lymphoid markers and comparison with epithelioid hemangioma.
Vargas AC, Maclean FM, Tsu KY, Ma L, Moir D. | 12/10/2022 |
| c-FOS Expression Analysis in Pterygia Cell Spot Arrays. | c-FOS Expression Analysis in Pterygia Cell Spot Arrays.
Mastronikolis S, Tsiambas E, Pagkalou M, Makri OE, Thomopoulou VK, Peschos D, Ragos V, Roukas D, Georgakopoulos CD., Free PMC Article | 10/1/2022 |
| Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression. | Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression.
Gupte R, Lin KY, Nandu T, Lea JS, Kraus WL., Free PMC Article | 08/13/2022 |
| Interleukin-1beta activated c-FOS transcription factor binds preferentially to a specific allele of the matrix metalloproteinase-13 promoter and increases susceptibility to endometriosis. | Interleukin-1β activated c-FOS transcription factor binds preferentially to a specific allele of the matrix metalloproteinase-13 promoter and increases susceptibility to endometriosis.
Pandit A, Das Mahapatra P, Saha P, Srivastava AK, Swarnakar S. | 07/23/2022 |
| FOS gene associated immune infiltration signature in perivascular adipose tissues of abdominal aortic aneurysm. | FOS gene associated immune infiltration signature in perivascular adipose tissues of abdominal aortic aneurysm.
Ding S, Gan T, Xiang Y, Zhu X, Jin Y, Ning H, Guo T, Zhao S, Xie J, Yuan Z. | 06/11/2022 |
| Role of Innate Immune Regulatory Genes, FOXP3 and FOS in Chronic Hepatitis B Infection. | Role of Innate Immune Regulatory Genes, FOXP3 and FOS in Chronic Hepatitis B Infection.
Borkakoty B, Sarmah MD, Majumdar T, Bhattacharjee CK, Baruah PJ, Biswas D, Kaur H. | 05/28/2022 |
| LncRNA CRART16/miR-122-5p/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression. | LncRNA CRART16/miR-122-5p/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression.
Zhang J, Pang X, Lei L, Zhang J, Zhang X, Chen Z, Zhu J, Jiang Y, Chen G, Wu Y, Wu T, Pan Y, Liu Y, Cui Y, Wang X., Free PMC Article | 05/28/2022 |
| Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatich cholangiocarcinoma. | Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatich cholangiocarcinoma.
He K, Feng Y, An S, Liu F, Xiang G. | 04/9/2022 |
| Regulation of c-Fos gene transcription by stimulus-responsive protein kinases. | Regulation of c-Fos gene transcription by stimulus-responsive protein kinases.
Dalhäusser AK, Rössler OG, Thiel G. | 03/19/2022 |
| Topoisomerase IIalpha represses transcription by enforcing promoter-proximal pausing. | Topoisomerase IIα represses transcription by enforcing promoter-proximal pausing.
Herrero-Ruiz A, Martínez-García PM, Terrón-Bautista J, Millán-Zambrano G, Lieberman JA, Jimeno-González S, Cortés-Ledesma F., Free PMC Article | 02/19/2022 |